• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Disord Drug Targets . Human ACE-2, MCP1 and micro-RNA 146 as Novel Markers for COVID- 19 Affection and Severity

tetano

Editor, Senior Moderator
Infect Disord Drug Targets


. 2022 Aug 29.
doi: 10.2174/1871526522666220829153042. Online ahead of print.
Human ACE-2, MCP1 and micro-RNA 146 as Novel Markers for COVID- 19 Affection and Severity


Amal Ahmed Mohamed[SUP] 1 [/SUP], Sherief Abd-Elsalam[SUP] 2 [/SUP], Ahmed Abdelghani[SUP] 3 [/SUP], Mohamed Badr Hassan[SUP] 3 [/SUP], Doaa Ghaith[SUP] 4 [/SUP], Omnia Ezzat[SUP] 5 [/SUP], Dalia Ali El-Damasy[SUP] 6 [/SUP], Norhan Nagdi Madbouli[SUP] 7 [/SUP], Mohmoud Hamada[SUP] 8 [/SUP], Mohamed Abdel Khalik Hepatology Gastroenterology And Infectious Diseases[SUP] 9 [/SUP], Shaimaa M Al-Tabbakh[SUP] 10 [/SUP], Kareman Ahmed Ebrahim Eshra[SUP] 11 [/SUP], Nivin Baiomy[SUP] 12 [/SUP]



Affiliations

Abstract

Background & aims: Coronavirus disease - 2019 (COVID-19) is a major pandemic that causes high morbidity and mortality rates.
Aim of this study: to detect the relations between many risk factors, ACE-2, MCP-1, Micro RNA 146 gene expression, and COVID-19 infection and disease severity.
Methods: This study was carried out on 165 cases of COVID-19 and 138 controls. ACE2 and MCP1 levels were measured in COVID-19 cases and control by ELISA and micro-RNA 146 expression by PCR.
Results: We found an increased blood level of ACE2 and MCP1 in COVID- 19 patients more than healthy persons, significant down-regulation of micro-RNA 146 gene expression in cases than in controls. There was a significant correlation between increased blood level of ACE2, regulation of micro-RNA 146 gene expression and severity of lung affection, a significant correlation was found between increased blood level of MCP1 and thrombosis in COVID-19 patients. Neurological complications were significantly correlated with more viral load, more ACE2 blood level, and down regulation of micro RNA146 expression.
Conclusions: High viral load, increased blood level of ACE2, and down-regulation of micro-RNA 146 expression are associated with more severe lung injury and with the presence of neurologic complications like convulsions and coma in COVID-19 Egyptian patients.

Keywords: ACE2; COVID-19; MCP1; Thrombosis; Viruses; micro RNA 146.
 
Back
Top Bottom